Metabolic diseases and pro- and prebiotics: Mechanistic insights
about
Mediterranean diet pyramid: a proposal for Italian people.Fermented Papaya Preparation Restores Age-Related Reductions in Peripheral Blood Mononuclear Cell Cytolytic Activity in Tube-Fed PatientsThe human microbiota associated with overall health.Gut microbiota, probiotics, and human healthEffect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial.Jussara (Euterpe edulis Mart.) supplementation during pregnancy and lactation modulates the gene and protein expression of inflammation biomarkers induced by trans-fatty acids in the colon of offspringThe overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures.Extracts of Rhizoma polygonati odorati prevent high-fat diet-induced metabolic disorders in C57BL/6 mice.Probiotics, prebiotics and the gastrointestinal tract in health and disease.A review on prebiotics and probiotics for the control of dysbiosis: present status and future perspectives.The role of probiotics on each component of the metabolic syndrome and other cardiovascular risks.Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota.Maternal Supplementation with Oligofructose (10%) during Pregnancy and Lactation Leads to Increased Pro-Inflammatory Status of the 21-D-Old Offspring.Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.An Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effects of a Multi-Strain Probiotic/Prebiotic, Antioxidant Intervention.Lipid-lowering effect of maize-based traditional Mexican food on a metabolic syndrome model in rats.Oligofructose supplementation (10%) during pregnancy and lactation does not change the inflammatory effect of concurrent trans fatty acid ingestion on 21-day-old offspring.Oligofructose as an adjunct in treatment of diabetes in NOD mice.Oligofructose supplementation during pregnancy and lactation impairs offspring development and alters the intestinal properties of 21-d-old pups.From meta-omics to causality: experimental models for human microbiome research.Functional foods as potential therapeutic options for metabolic syndrome.Intestinal Microbiome, Akkermansia muciniphila, and Medical Nutrition Therapy.Prebiotic Dietary Fiber and Gut Health: Comparing the in Vitro Fermentations of Beta-Glucan, Inulin and Xylooligosaccharide.Probiotic strains and mechanistic insights for the treatment of type 2 diabetes.Consumption of Bifidobacterium animalis subsp. lactis BB-12 in yogurt reduced expression of TLR-2 on peripheral blood-derived monocytes and pro-inflammatory cytokine secretion in young adults.Effect of the consumption of green tea extract during pregnancy and lactation on metabolism of mothers and 28d-old offspring.Dietary xylooligosaccharide downregulates IFN-γ and the low-grade inflammatory cytokine IL-1β systemically in mice
P2860
Q27691301-4830CC2E-38BA-4757-86D5-3CC7D900914CQ28468408-5466BC94-6E95-47B5-904E-B7B4A7C1BEB0Q31125776-5EB6CD4E-47ED-40A0-B8E7-7210C83B085BQ33666412-B4BD1027-E068-4D5B-984E-6D1F81753955Q33904838-A6B52E5B-F8E1-4B24-9104-8C10D59ADAE5Q34222707-04136FD7-1FC4-48DE-8A6A-9F1C0CA1A59CQ34309689-83B4C966-A39E-4975-AC4D-6065500D26CAQ35060670-61C2F2E7-9967-4653-A684-155F6DB97B1DQ35122167-D1BB042F-D1E3-4BD6-8410-77823F09867EQ35356969-FA75EC3D-4E2A-4E2B-BE0C-8B3CF04B3144Q35601130-435306CA-3524-4D10-9308-065C07A8B90DQ35671765-A48CC463-769F-47ED-A8B5-12CF1368C17BQ35683224-474ECF7B-DE17-4760-9857-14A89BEA20D2Q36005129-9A11F44D-E51C-4459-BD13-9C41A7C4D710Q36199294-B316E811-9114-4AF2-8DFF-9E9A8D8A92F0Q36715899-B1513E7F-4DDE-4040-96CA-D40DE82FEFD6Q36843344-88600E62-29A5-4127-883E-02E4F4E35860Q37428004-978F5F03-DAEA-40F3-8037-F7A5F6ECFB17Q37590784-2D10AB33-3672-464A-AC4C-399738B42748Q37677334-147B22EE-FB32-4F2A-87C2-89F5CF840FCAQ38582214-A2CF7AE4-514C-4B92-8F27-DF9B7B597719Q42356286-865EB12C-F030-4E7B-9E00-C6389E3DE6F7Q46240377-A80B4FB4-8C34-40F7-BE5B-8DA71BDE0DB1Q46279792-97598C09-E519-47A4-A792-0B8D7EAC3771Q46631537-9DE92DB3-1129-4D96-BB3A-7B4B1D0BB774Q47547975-0D56E0C8-188F-4E29-9790-8858FBC182F0Q57113406-278F5511-CE35-4820-86F9-A20EED385BAC
P2860
Metabolic diseases and pro- and prebiotics: Mechanistic insights
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Metabolic diseases and pro- and prebiotics: Mechanistic insights
@ast
Metabolic diseases and pro- and prebiotics: Mechanistic insights
@en
type
label
Metabolic diseases and pro- and prebiotics: Mechanistic insights
@ast
Metabolic diseases and pro- and prebiotics: Mechanistic insights
@en
prefLabel
Metabolic diseases and pro- and prebiotics: Mechanistic insights
@ast
Metabolic diseases and pro- and prebiotics: Mechanistic insights
@en
P2860
P356
P1476
Metabolic diseases and pro- and prebiotics: Mechanistic insights
@en
P2093
Yukiko K Nakamura
P2860
P2888
P356
10.1186/1743-7075-9-60
P577
2012-06-19T00:00:00Z
P5875
P6179
1039446651